Humacyte HUMA
NASDAQ HUMA
$0.68 -0.05 (-6.85%)
At close: Aug 20, 2026 · 4:00 PM EDT

Humacyte (HUMA) Change in Inventory (2025 - 2026)

Humacyte (HUMA) posted quarterly Change in Inventory of -$2.0 million for Q1 2026, down 125.47% year-over-year from $8.0 million in Q1 2025, and down 157.44% quarter-over-quarter from $3.6 million in Q4 2025.

Humacyte (HUMA) Change in Inventory (2025 - 2026) Analysis & Trends

Humacyte (HUMA) has reported Change in Inventory for 2 consecutive years, with -$2.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Inventory fell 125.47% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at $11.8 million (up 46.68% YoY), while the FY2025 annual figure was $21.8 million, changed N/A from the prior year.
  • Change in Inventory eased to -$2.0 million in Q1 2026 per HUMA's latest filing, from $3.6 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $8.0 million in Q1 2025 and bottomed at -$2.0 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 27.70 Mn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 28.20 Mn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 132.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 47.15 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -280,000.00
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 12.97 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 135.26 Mn
10 Humacyte 158.12 Mn 158.12 Mn -825,000.00 -2.27 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.27 Mn
Jun 30, 2026 -2.27 Mn
Mar 31, 2026 -2.04 Mn
Mar 31, 2026 -2.04 Mn
Dec 31, 2025 3.56 Mn
Dec 31, 2025 3.56 Mn
Sep 30, 2025 7.30 Mn
Sep 30, 2025 7.30 Mn
Jun 30, 2025 2.95 Mn
Jun 30, 2025 2.95 Mn
Mar 31, 2025 8.02 Mn
Mar 31, 2025 8.02 Mn